Abbott Laboratories (ABT) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Abbott Laboratories (ABT) is Neutral.

The composite score behind that read is -0.01, weighing +0.26 of bullish evidence against -0.26 bearish.

Abbott Laboratories last closed at $99.60, +1.13% on the session.

Against the IVW growth benchmark the position is +0.33% over the forecast window.

The read is built from 15 underlying insights — 2 bullish and 13 bearish.

Agreement across those insights is 87%.

4 graded predictions for ABT so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Abbott Laboratories in the 26th percentile on valuation and the 61st percentile on return on equity, where 100 is best.

Abbott Laboratories is classified under Health Care / Health Care Equipment & Supplies, with a market capitalisation of $170.43B.

StockMap tracks Abbott Laboratories as the 1st largest of the 140 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 122 Neutral, 16 Moderate Underperform and 2 Moderate Outperform.

On that composite Abbott Laboratories ranks 51st of 140 in the group, against a group median of -0.03.